Senior Director, Medidata AI
Rachel is the Product Lead for our newly launched Trial Impact Analytics offering, which helps companies navigate the evolving COVID-19 environment and inform critical decisions as it relates to recovery planning. Prior to this role, she was the Head of Strategic Initiatives and led the launch of the Medidata Institute. Before joining Medidata, Rachel spent several years at Bain & Co. and Rothschild, advising healthcare and technology companies on a broad range of strategic issues and decisions. She holds a Master in Biomedical Engineering from the University of Bern in Switzerland, as well as an MBA from the MIT Sloan School of Management and a BS in Economics from The Wharton School, University of Pennsylvania.